Carna Biosciences Inc
TSE:4572
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
JP |
Carna Biosciences Inc
TSE:4572
|
7.6B JPY | 3.3 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 14.3 | ||
US |
Danaher Corp
NYSE:DHR
|
184.8B USD | 7.6 | ||
US |
Agilent Technologies Inc
NYSE:A
|
41.8B USD | 12.5 | ||
CH |
Lonza Group AG
SIX:LONN
|
38B CHF | 16.2 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.4B USD | 10.1 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 30.4 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
27B USD | 12.8 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 24.1 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.8B USD | 11.8 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
18.8B EUR | 18.1 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.